Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf,...
-
date post
21-Dec-2015 -
Category
Documents
-
view
218 -
download
2
Transcript of Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf,...
![Page 1: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/1.jpg)
Investment opportunities in the health sector in Europe, focussing on Germany
Dr. Simone Breitkopf, BPI
Dr. Rudolf Schosser, Consultant
![Page 2: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/2.jpg)
World Pharma Market by Regions 2007
European Pharmaceutical market:
213,1 billion US$
Source: IMS World Review 2008
![Page 3: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/3.jpg)
Europe: Central and Regional
27 countries
493 Mio. population
Pharmaceutical market: 213,1 billion US$
Administration
Legislation
Pharmaceutical regulations
Marketing authorization
Different health care systems
Different health insurance and reimbursement systems
Very complex environment!
![Page 4: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/4.jpg)
German Pharmaceutical Market
1.031 pharmaceutical companies
395 biotech companies
Pharmaproduction: 26,2 billion EURO
R&D-Expenditure: 5,8 billion EURO
Turnover in German Pharmacy Market (22,8 billion EURO):
• 17,7 billion EURO Rx-Products
• 2,9 billion EURO „pharmacy only“-Products
Source: BPI-Pharma-Daten 2008
![Page 5: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/5.jpg)
Exports and Imports of Pharmaceuticals in Germany
Year Import Export
Mill. Euro +/- % Mill. Euro +/- %
2000 10,353.47 +25.9 15,177.47 +5.9
2001 12,051.17 +16.4 20,478.36 +34.9
2002 19,284.83 +60.0 18,835.18 -8.0
2003 19,327.83 +0.2 22,230.11 +18.0
2004 22,221.42 +15.0 28,681.63 +29.0
2005 25,585.17 +15.1 31,758.85 +10.7
2006 28,366.72 +10.9 36,474.52 +14.8
2007 32,601.23 +14.9 41,748.66 +14.5
Source: German Federal Statistical Office (Destatis), 2008
![Page 6: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/6.jpg)
Price structure
4,1
11,8
53,6
16,7
13,8
Manufacturer Wholesaler Pharmacy Tax Rebate
Source: BPI-Pharma-Daten
![Page 7: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/7.jpg)
Healthcare Sector in Germany
• 90% of the population is insured in about 220 statutory health insurances (GKV).
• About 10% of the population is insured by 50 private health insurances.
• GKV-Expenditure: 153,6 billion EURO• Medicinal Products: 25,6 billion EURO (16,7 %)
![Page 8: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/8.jpg)
Generics market in Germany
• Growing market
• Highly competitive
• Complex reimburse-ment situation
Opportunities for Indian pharmaceutical
companies?!
![Page 9: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/9.jpg)
Growing Number of Chronic Diseases
Source: WHO
% of population
![Page 10: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/10.jpg)
Growing OTC Market
• Covering pharmacy-only products, freely available products and general health products
• OTC sales trends in 2007 dominated by pharmacy-only products with 82.0% of the market.
• Every fifth non-prescription product sold at pharmacies is not pharmacy-only (percentage sales: 18.3%).
![Page 11: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/11.jpg)
Market entry in Germany …
is a rough cruise
requires professionalism
and strong local partners
• e.g. BPI e.V. and BPI-Service GmbH
• knowledgeable consultants and
• service providers
![Page 12: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/12.jpg)
Shortening time to market
Sequential approachDecision to explore market entry
Decision to enter market
Subsidiary established
Launch of product(s)
Market entry research Establish subsidiary Obtain marketing authorization + build up infrastructure (in case of greenfield approach)
Parallel approachDecision to explore market entry
Decision to enter market
Subsidiary established
Launch of product(s)
Market entry research Establish subsidiary
Obtain marketing authorization + (optional) build up infrastructure
![Page 13: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/13.jpg)
You need …
…a local team in which each member knows exactly what has to be done at the right time in the right order
![Page 14: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/14.jpg)
You need …
…a crew which is highly motivated and aligned to the goal of bringing your drug onto the market
![Page 15: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/15.jpg)
You need …
….to avoid unnecessary collisions and get the ship safely to the harbor of destination (= marketing authorization and reimbursement)
….a captain…a navigator and…a helmsman….
![Page 16: Investment opportunities in the health sector in Europe, focussing on Germany Dr. Simone Breitkopf, BPI Dr. Rudolf Schosser, Consultant.](https://reader035.fdocuments.net/reader035/viewer/2022062407/56649d6b5503460f94a4aeee/html5/thumbnails/16.jpg)
Thank you for your attention